Menu
Venture Life
About Us
At a Glance
History
Business Model
Our Strategy
Market Overview
Our Products
Development & Manufacturing
Board of Directors
Corporate Responsibility
Corporate Governance
Awards
Development & Manufacturing
Our Products
Oral Healthcare
UltraDEX
UltraDEX Mouthwash
UltraDEX Toothpaste
UltraDEX Accessories
Dentyl Dual Action
Dentyl Dual Action Mouthwash
Dentyl Dual Action BB Mints
Proctology
Procto-eze Plus
Dermatology
Myco Clear
Rosa calma
Bioscalin
Lubatti
Lubatti Classic
Lubatti Anti-Ageing
Women’s Healthcare
vonalei
vonalei – Bacterial Vaginosis
vonalei – Vaginal Atrophy
vonalei – Candidiasis
vonalei – Intimate Cleansing Foam
Glucose Management
Lift Glucose
Lift Glucose Shots
Lift Glucose Tablets
Glucogel
ENT Care
Earol®
EarolSwim®
Sterinase®
Oncology Support
Pomi-T
Gelclair
Xonrid
Our Partners
Investor Relations
Investment Case
Results, Reports and Presentations
Shareholder & Company Documents
Share Price Tools
AIM Rule 26
Corporate Governance
Board of Directors
Regulatory News
Press Releases
Shareholder Analysis
Advisors & Registrar
Analysts
Video & Audio Presentations
Investor Relations Contact
Contact Us
Investor Relations
Press Releases
2022
Archive
10th October 2022
Directorate Changes
PDF
(243.41kB)
Download
19th June 2020
Investor Chronicle’s “Four small-cap situations offering outperformance” article by Simon Thompson
PDF
(3.56MB)
Download
15th October 2018
Evening Standard article
PDF
(181.25kB)
Download
Related Links
Investment Case
Find out more
Share Price Tools
Find out more
Results, Reports and Presentations
Find out more
Interested in knowing more?
Keep up to date with our email alerts.
Follow us